HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rea, F. Articles by Altavilla, G. Search for Related Content PubMed PubMed Citation Articles by Rea, F. Articles by Altavilla, G.

The Journal of Thoracic and Cardiovascular Surgery, Vol 106, 543-549, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Chemotherapy and operation for invasive thymoma

F Rea, F Sartori, M Loy, F Calabro, A Fornasiero, O Daniele and G Altavilla
Department of Thoracic Surgery, University of Padua, Italy.

Sixteen patients with invasive thymoma (stage III and stage IVA) were treated with chemotherapy and then operation. All tumors were considered nonresectable after first staging, and patients were treated with the following chemotherapy in 4-day courses, administered intravenously: cisplatin (50 mg/m2) and doxorubicin (40 mg/m2) on day 1, vincristine (0.6 mg/m2) on day 3, and cyclophosphamide (700 mg/m2) on day 4. The courses were repeated every 3 weeks, and toxic effects were well tolerated. Seven patients (43%) had a complete remission, and nine patients (57%) had a partial remission, with an overall complete remission plus partial remission rate of 100%. After chemotherapy all patients underwent operation. We performed 12 sternotomies and four posterolateral thoracotomies. At operation 11 patients had radical resection and five had partial resection. We administered radiotherapy in 11 patients who had histologically demonstrated tumor after operation. In five patients, the specimen showed only fibrosis; these patients received three cycles of chemotherapy but not radiotherapy. Median survival was 66 months with a 3-year survival of 70%. We believe that neoadjuvant chemotherapy with surgical intervention is justified for advanced invasive thymoma; a longer follow-up and a larger number of patients will determine the impact of this treatment on long-term survival.

This article has been cited by other articles:

				M. F. K. Benveniste, M. L. Rosado-de-Christenson, B. S. Sabloff, C. A. Moran, S. G. Swisher, and E. M. Marom Role of Imaging in the Diagnosis, Staging, and Treatment of Thymoma RadioGraphics, November 1, 2011; 31(7): 1847 - 1861. [Abstract] [Full Text] [PDF]

				G. Marulli, M. Lucchi, S. Margaritora, G. Cardillo, A. Mussi, G. Cusumano, F. Carleo, and F. Rea Surgical treatment of stage III thymic tumors: a multi-institutional review from four Italian centers Eur J Cardiothorac Surg, March 1, 2011; 39(3): e1 - e7. [Abstract] [Full Text] [PDF]

				G. Cardillo, F. Carleo, R. Giunti, M. G. Lopergolo, L. Salvadori, A. R. De Massimi, L. Petrella, and M. Martelli Predictors of survival in patients with locally advanced thymoma and thymic carcinoma (Masaoka stages III and IVa) Eur J Cardiothorac Surg, April 1, 2010; 37(4): 819 - 823. [Abstract] [Full Text] [PDF]

				F. Venuta, M. Anile, D. Diso, D. Vitolo, E. A. Rendina, T. De Giacomo, F. Francioni, and G. F. Coloni Thymoma and thymic carcinoma Eur J Cardiothorac Surg, January 1, 2010; 37(1): 13 - 25. [Abstract] [Full Text] [PDF]

				Y. Ishikawa, H. Matsuguma, R. Nakahara, H. Suzuki, A. Ui, T. Kondo, Y. Kamiyama, S. Igarashi, K. Mori, T. Kodama, et al. Multimodality Therapy for Patients With Invasive Thymoma Disseminated Into the Pleural Cavity: The Potential Role of Extrapleural Pneumonectomy Ann. Thorac. Surg., September 1, 2009; 88(3): 952 - 957. [Abstract] [Full Text] [PDF]

				M. Lucchi, F. Basolo, and A. Mussi Surgical treatment of pleural recurrence from thymoma Eur J Cardiothorac Surg, April 1, 2008; 33(4): 707 - 711. [Abstract] [Full Text] [PDF]

				J. Huang, G. J. Riely, K. E. Rosenzweig, and V. W. Rusch Multimodality Therapy for Locally Advanced Thymomas: State of the Art or Investigational Therapy? Ann. Thorac. Surg., February 1, 2008; 85(2): 365 - 367. [Full Text] [PDF]

				C. D. Wright, N. C. Choi, J. C. Wain, D. J. Mathisen, T. J. Lynch, and P. Fidias Induction Chemoradiotherapy Followed by Resection for Locally Advanced Masaoka Stage III and IVA Thymic Tumors Ann. Thorac. Surg., February 1, 2008; 85(2): 385 - 389. [Abstract] [Full Text] [PDF]

				J. Huang, N. P. Rizk, W. D. Travis, V. E. Seshan, M. S. Bains, J. Dycoco, R. J. Downey, R. M. Flores, B. J. Park, and V. W. Rusch Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1477 - 1484. [Abstract] [Full Text] [PDF]

				R. F. Riedel and W. R. Burfeind Jr Thymoma: Benign Appearance, Malignant Potential Oncologist, September 1, 2006; 11(8): 887 - 894. [Abstract] [Full Text] [PDF]

				C. D. Wright, J. C. Wain, D. R. Wong, D. M. Donahue, H. A. Gaissert, H. C. Grillo, and D. J. Mathisen Predictors of recurrence in thymic tumors: Importance of invasion, World Health Organization histology, and size J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1413 - 1421. [Abstract] [Full Text] [PDF]

				F. Rea, G. Marulli, R. Girardi, L. Bortolotti, A. Favaretto, A. Galligioni, and F. Sartori Long-term survival and prognostic factors in thymic epithelial tumours Eur J Cardiothorac Surg, August 1, 2004; 26(2): 412 - 418. [Abstract] [Full Text] [PDF]

				A. D. Trobaugh-Lotrario, X. Liang, J. S. Janik, M. A. Lovell, and L. F. Odom Difficult Diagnostic and Therapeutic Cases: CASE 2. Thymoma and Tumor Lysis Syndrome in an Adolescent J. Clin. Oncol., March 1, 2004; 22(5): 955 - 957. [Full Text] [PDF]

				F. Venuta, E. A. Rendina, F. Longo, T. De Giacomo, M. Anile, E. Mercadante, L. Ventura, M. F. Osti, F. Francioni, and G. F. Coloni Long-term outcome after multimodality treatment for stage III thymic tumors Ann. Thorac. Surg., December 1, 2003; 76(6): 1866 - 1872. [Abstract] [Full Text] [PDF]

				Y. Refaely, D. A. Simansky, M. Paley, M. Gottfried, and A. Yellin Resection and perfusion thermochemotherapy: a new approach for the treatment of thymic malignancies with pleural spread Ann. Thorac. Surg., August 1, 2001; 72(2): 366 - 370. [Abstract] [Full Text] [PDF]

				C. R. Thomas, C. D. Wright, and P. J. Loehrer Thymoma: State of the Art J. Clin. Oncol., July 1, 1999; 17(7): 2280 - 2280. [Abstract] [Full Text] [PDF]

				M. Okumura, S. Miyoshi, Y. Takeuchi, H.-E. Yoon, M. Minami, S.-I. Takeda, Y. Fujii, K. Nakahara, and H. Matsuda Results Of Surgical Treatment Of Thymomas With Special Reference To The Involved Organs J. Thorac. Cardiovasc. Surg., March 1, 1999; 117(3): 605 - 611. [Abstract] [Full Text]

				F. Venuta, E. A. Rendina, E. O. Pescarmona, T. De Giacomo, M. L. Vegna, P. Fazi, I. Flaishman, E. Guarino, and C. Ricci Multimodality Treatment of Thymoma: A Prospective Study Ann. Thorac. Surg., December 1, 1997; 64(6): 1585 - 1591. [Abstract] [Full Text]

				K. Yagi, T. Hirata, T. Fukuse, H. Yokomise, K. Inui, O. Ike, H. Mizuno, M. Aoki, S. Hitomi, and H. Wada Surgical Treatment for Invasive Thymoma, Especially When the Superior Vena Cava Is Invaded Ann. Thorac. Surg., February 1, 1996; 61(2): 521 - 524. [Abstract] [Full Text]

				D. Blumberg, J. L. Port, B. Weksler, R. Delgado, J. Rosai, M. S. Bains, R. J. Ginsberg, N. Martini, P. M. McCormack, V. Rusch, et al. Thymoma: A multivariate analysis of factors predicting survival Ann. Thorac. Surg., October 1, 1995; 60(4): 908 - 914. [Abstract] [PDF]